A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children
NCT01218308
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
5220
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
FluLaval® Quadrivalent
BIOLOGICAL:
Havrix™
Sponsor
GlaxoSmithKline